MétaCan
Menu
Back to cohort
Record W2093640792 · doi:10.1055/s-2009-1216411

Sourcing of Quality Raw Materials for Indian System of Medicine (ISM) and Botanical Drugs

2009· article· en· W2093640792 on OpenAlexfundno aff
YS Bedi, HC Dutt

Bibliographic record

VenuePlanta Medica · 2009
Typearticle
Languageen
FieldAgricultural and Biological Sciences
TopicEthnobotanical and Medicinal Plants Studies
Canadian institutionsnot available
FundersNational Institute on Drug AbuseAgricultural Research ServiceUniversity of British ColumbiaUniversity of Illinois at Urbana-ChampaignChinese Academy of SciencesKurukshetra UniversityUniversity of Illinois at ChicagoNational Oceanic and Atmospheric AdministrationU.S. Food and Drug AdministrationNational Science Foundation of Sri LankaUniversity of ColomboU.S. Department of AgricultureWestern Carolina UniversityInternational Science CouncilNational Center for Complementary and Alternative MedicineChina Academy of Traditional Chinese MedicineNational Institutes of HealthNational Center for Research ResourcesNational Institute of Allergy and Infectious DiseasesTürkiye Bilimsel ve Teknolojik Araştırma KurumuHong Kong Polytechnic UniversityNational Science FoundationDeutsche KrebshilfeNational Natural Science Foundation of ChinaTata TrustsUniversity Grants CommissionWake Forest University
KeywordsBusinessRaw materialProduct (mathematics)Quality (philosophy)BiotechnologyMarketingAgricultural economicsCommerceNatural resource economicsEconomicsBiology

Abstract

fetched live from OpenAlex

Globally, there has been an unparalleled growth in the plant-derived medicinally useful formulations, drugs and health care products, with annual growth rates between 10–20% in most of the countries. According to WHO, the international market of herbal products is estimated to be US$ 62 billion which is poised to grow to US$ 5 trillion by the year 2050. This has attracted many large pharmaceutical and consumer product companies worldwide to have herbals/botanicals in their product portfolio. India is no exception to it and has a competitive edge as Indian Traditional drugs/products, have their roots in time tested systems of medicine namely, Ayurveda, Unani and Siddha. Renewed interest in botanical products has resulted into a huge international trade in raw plant material, feeding a range of such industries, including the $20 billion botanical medicine market. Presently between 75 and 85% of the raw materials for the botanical industry are sourced from wild. Due to the increasing public demand for quality botanical products, some companies are now making efforts to acquire at least a portion of their raw material from sustainable and ethical sources, but most invest little in this side of their business. The existing industry practice often promotes poor management of species and few benefits for the collectors and cultivators, and many companies remain distant and unaware of the conditions under which raw materials are sourced. However, there also exist opportunities to create change in this sector. The source and quality of raw materials, storage, post-harvest handling play a pivotal role in guaranteeing the quality and stability of ISM & botanical preparations. In India, in addition to the promotion of cultivation of medicinal and aromatic plants (MAPs) by certain government departments and R&D institutes, of late some private herbal drug industries have also started sourcing their requirement of herbal raw material from cultivated sources. The cultivation of MAPs, on the other hand, would not only lead to better control over quality of the end products but will also reduce anthropogenic stress on wild stands. The presentation will illustrate the efforts being made in India in general and at the Indian Institute of Integrative Medicine (IIIM – CSIR) in particular for the sourcing and sustainable supply of raw materials for ISM & Botanical industry.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.049

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0010.001
Scholarly communication0.0020.000
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0150.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.283
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2009
Admission routes1
Has abstractyes

Explore more

Same venuePlanta MedicaSame topicEthnobotanical and Medicinal Plants StudiesFrench-language works237,207